問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-02-03 - 2024-01-25
Condition/Disease
generalized myasthenia gravis
Test Drug
Rozanolixizumab
Participate Sites5Sites
Not yet recruiting3Sites
Recruiting1Sites
Study ended1Sites
2021-01-22 - 2023-03-23
Participate Sites10Sites
Not yet recruiting2Sites
Recruiting8Sites
2021-04-01 - 2022-09-30
Primary Immune Thrombocytopenia
Participate Sites8Sites
Not yet recruiting8Sites
2014-09-01 - 2016-07-31
Participate Sites2Sites
Terminated2Sites
2013-11-01 - 2015-01-31
2014-05-01 - 2018-06-30
Participate Sites1Sites
Terminated1Sites
2013-06-01 - 2015-02-20
Participate Sites3Sites
Terminated3Sites
2020-07-01 - 2024-01-03
2019-09-01 - 2021-09-30
2018-12-31 - 2020-12-31
Skin Rash in Subjects with EGFR Inhibitor Therapy
AC-701(Berberine) Gel:0.3%
Recruiting2Sites
全部
